Discovery of Q‐Markers of Mudan Granules by Chemical Profile, Pharmacokinetics, Neuroprotective Effect Evaluation, and Network Pharmacology

Documenti analoghi

• Identification of Xuanfei Baidu granule constituents by liquid chromatography–quadruple‐time‐of‐flight–mass spectrometry and its anti‐inflammatory active constituents using a lipopolysaccharide‐induced RAW264.7 cell model
  di: Haoran Li, et al.
  Pubblicazione: (2024)
• Identification and quantification of the antioxidants in Ginkgo biloba leaf
  di: Chenxiu Hu, et al.
  Pubblicazione: (2024)
• Identification and Multidimensional Evaluation of Quality Markers in Yupingfeng via UPLC‐Q‐Orbitrap‐MS, Network Pharmacology, UPLC‐UV Fingerprint, and UPLC‐QQQ‐MS
  di: Shu Li, et al.
  Pubblicazione: (2026)
• Integrated Characterization and Pharmacokinetics of Kanli Granule in Rats Based on UPLC‐Q‐TOF‐MS/MS: In Vitro and In Vivo Component Screening
  di: Xuehao Cheng, et al.
  Pubblicazione: (2026)
• Exploring the Potential Mechanism of Ru‐Pi‐Ning Granules Against Mammary Gland Hyperplasia Based on UPLC‐Q‐TOF‐MS and Network Pharmacology
  di: Mengjun Pan, et al.
  Pubblicazione: (2026)